cervical cancer tissues; adjacent normal tissues
SiHa; C33A; CaSki; Hela; HeLa; HCerEpiC
cell line-derived xenograft
ceRNA regulation (promotes); proliferation (promotes); cell cycle (promotes); migration (promotes); invasion (promotes); metastasis (promotes)
RT-qPCR; Microarray; Clinical Sample Validation; Nuclear-Cytoplasmic Fractionation; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Cell Cycle Assay; Transwell Assay; In Vivo Animal Model; Survival Analysis; Cohort Study
High hsa_circRNA_101996 expression is positively correlated with TNM stage, tumor size, and lymph node metastasis, and is associated with poor survival of cervical cancer patients.
hsa_circRNA_101996 is up-regulated in cervical cancer tissues and cell lines, and high expression is associated with advanced stage, larger tumor size, lymph node metastasis, and poor survival. Functionally, it promotes cervical cancer proliferation, cell cycle progression, migration, invasion, and xenograft tumor growth. Mechanistically, it acts as a cytoplasmic miR-8075 sponge to increase TPX2 expression, forming a hsa_circRNA_101996-miR-8075-TPX2 regulatory network that promotes cervical cancer progression.
0.7733
CircRNA hsa_circRNA_101996 increases cervical cancer proliferation and invasion through activating TPX2 expression by restraining miR-8075.
combined biological and clinical study